Listen

Description

Weight gain can impact patient’s quality of life and put them at risk for health complications. While weight loss can be an important factor in a patient’s health, it is equally important that it is done safely and effectively. Listen in as host, Geoff Wall compares the safety and efficacy of semaglutide and liraglutide in weight loss. 

The GameChanger:

• Based on a recent Phase-3 study, semaglutide appears to be more effective in weight loss than liraglutide 
• Semaglutide also appeared to have modest effects on decreasing systolic blood pressure, blood sugar, lipid concentrations, and serum insulin levels
• GLP-1 agonists are expensive medications – patients should be made aware of the of the associated cost as a part of patient centered care 

Show Segments:

00:00 – Introductions

01:10 – GLP-1s Agonist (Semaglutide vs Liraglutide) in Weight Management

10:00 – Change in Body Weight 

12:02 – Secondary Outcomes – Blood Pressure, Blood Sugar, Lipid Concentrations, & Serum Insulin

12:59 – Safety & Side Effects

14:15 – Cost

14:52 – The GameChanger

17:20 – Closing Remarks

Links to Resources:

Effects of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults with Overweight or Obesity Without Diabetes

How to Claim CE:

CE is available for CEimpact members:

·       Click here to claim CPE Credit 

·       Click here to claim CME Credit 

Need a membership?

• Join for CPE Credit 
•  Join for CME Credit

Continuing Education Information:
Learning Objectives:
1. Describe the inclusion and exclusion criteria of the STEP 8 study
2. Discuss the outcomes of the STEP 8 study

Dr. Wall is a member of the Janssen Speaker's Bureau.

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-088-H01-P
Initial release date: 02/14/22
Expiration date: 02/14/2023
Additional CPE & CME details can be found here"

Follow CEimpact on Social Media:
LinkedIn
Instagram